仙琚制药(002332) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥1,008,198,242.30, a decrease of 2.86% compared to ¥1,037,926,735.62 in the same period last year[5] - Net profit attributable to shareholders was ¥143,983,992.29, down 4.72% from ¥151,121,862.92 year-on-year[5] - Basic earnings per share were ¥0.1456, reflecting a decline of 4.71% from ¥0.1528 in the same period last year[5] - Net profit for the current period is ¥138,163,788.77, a decline of 11.7% compared to ¥156,516,313.26 in the previous period[21] - Other comprehensive income after tax for the current period is ¥46,221,040.19, compared to a loss of ¥30,172,868.95 in the previous period[22] - The total comprehensive income for the current period is ¥184,384,828.96, an increase from ¥126,343,444.31 in the previous period[22] Cash Flow - The net cash flow from operating activities decreased by 83.10%, amounting to ¥18,421,732.02, compared to ¥109,025,001.56 in the previous year[5] - Cash inflow from operating activities totaled ¥809,426,287.89, slightly down from ¥825,567,894.71 in the previous period[23] - The net cash flow from operating activities was 18,421,732.02, a decrease from 109,025,001.56 in the previous period[24] - The net cash flow from investing activities was -69,733,941.91, compared to -63,759,854.47 previously, indicating increased investment outflows[24] - The net cash flow from financing activities was 5,132,399.86, a significant improvement from -15,199,172.59 in the prior period[24] - The cash outflow from operating activities totaled 791,004,555.87, compared to 716,542,893.15 previously, reflecting higher operational expenses[24] - The cash inflow from financing activities was 10,206,279.63, up from 500,000.00, indicating increased capital raising efforts[24] - The company paid 79,196,674.94 in taxes, an increase from 63,414,473.05, reflecting higher tax obligations[24] - The cash outflow for investing in fixed assets was 69,740,347.25, compared to 39,871,581.52, showing increased capital expenditures[24] Assets and Liabilities - Total assets increased by 1.84% to ¥7,128,642,277.18 from ¥6,999,589,209.69 at the end of the previous year[5] - Current assets totaled CNY 3,327,667,195.76, compared to CNY 3,263,717,834.91 at the start of the period, indicating a growth in liquidity[17] - The company's cash and cash equivalents decreased slightly to CNY 1,363,055,340.05 from CNY 1,381,890,699.25[16] - Total liabilities decreased to CNY 716,880,084.65 from CNY 778,089,858.12, indicating improved financial health[17] - The total liabilities amount to ¥1,055,185,380.16, a decrease from ¥1,111,417,141.63 in the previous period[18] - Long-term borrowings increased to ¥22,686,715.44 from ¥20,400,448.86 in the previous period[18] Shareholder Equity - The company's equity attributable to shareholders rose by 3.25% to ¥6,033,708,337.97 from ¥5,843,503,305.49 at the end of last year[5] - Total equity attributable to shareholders of the parent company increased to ¥6,033,708,337.97 from ¥5,843,503,305.49 in the previous period[18] Operational Metrics - The company reported a significant decrease in net cash flow from operating activities, primarily due to reduced cash receipts from sales and increased cash payments related to operating activities[9] - Short-term borrowings increased by 63.19%, amounting to an increase of ¥5,377,500 compared to the beginning of the year[12] - The company experienced a 341.78% increase in other comprehensive income, rising by ¥46,221,000, mainly due to foreign currency translation differences[12] - Financial expenses increased by 53.16%, amounting to an increase of ¥3,113,100, primarily due to reduced interest income[12] - Accounts receivable increased to CNY 668,550,016.07 from CNY 561,934,184.47, reflecting improved sales performance[16] - Inventory levels remained stable, with a slight decrease to CNY 922,328,200.69 from CNY 930,856,320.79[16] - The company's goodwill increased to CNY 602,096,680.76 from CNY 581,206,099.17, indicating potential acquisitions or investments[17] - The company reported a total of CNY 185,539,442.57 in other payables, slightly up from CNY 182,736,655.29, reflecting stable operational liabilities[17] - The company has not reported any significant changes in its major shareholders or their holdings during the period[14]